

Our President and CEO, Daozhan Yu, along with CTO Qizhao Wang, will represent AAVnerGene at the SAPA-CT 2024 Annual Conference this Saturday at Yale University!
đ Donât miss Daozhanâs presentation, âNew Technologies to Enhance AAV Gene Therapy Efficiency,â happening from 11:45 AM – 12:05 PM.
đ
Date: Saturday, December 7, 2024
đ Time: 8:30 AM – 5:30 PM (Dinner: 6:00 PM – 9:00 PM)
đ Location: TAC Auditorium, Yale University
(300 Cedar Street, New Haven, CT, 06511)
Conference Main Topics:
- Â Cutting-edge Technology in Drug Discovery
- Â Accelerating Drug Discovery with Big Data AI
- Â New Trends in Translational Medicine
- Â Career Development Workshop
- Â Startup Pitch Contest
⨠AAVnerGene is a leading biotech company specializing in advanced gene therapy technologies. We specialize in innovative gene therapy solutions powered by advanced AAV technologies. Hereâs what we offer:
â
AAV Vector Design and Optimization
â
Custom AAV Packaging Services
â
Comprehensive AAV Analysis
â
Capsid Libraries Construction and Production
â
Capsid Selection and Directed Evolution
â
Experiment Consultation and Strategic Support
Weâre thrilled to connect with industry leaders, share insights, and explore collaborations to advance the future of gene therapy. Together, letâs drive innovation and create a brighter future for patients.
đ See you at SAPA-CT 2024!
#GeneTherapy #AAV #Innovation #Biotech #SAPA2024 #TranslationalMedicine #DrugDiscovery #Partnerships #AAVnerGene #Biotechnology
